Literature DB >> 33643223

Immunological Features of Paranasal Sinus Mucosa in Patients with Graves' Orbitopathy.

Yi Lu1,2, Yu Wu1,2, Yazhuo Huang1,2, Sijie Fang1,2, Yinwei Li1,2, Jing Sun1,2, Huifang Zhou1,2.   

Abstract

Background: Previous studies showed that patients with Graves' orbitopathy (GO) had concomitant mucosal abnormality within the paranasal sinuses. It remains unknown whether the immunological reactions in sinus mucosa affect the orbit inflammation in GO.
Methods: Patients with GO underwent sinus computed tomography (CT) scans for sinus mucosal disease by two independent reviewers using the Lund-MacKay systems. Ethmoid mucosal samples were collected during orbital decompression surgeries for patients with GO and correction surgeries for patients with old orbital fractures as controls. Histological analysis and immunofluorescence were performed in all sinus mucosa tissues. Flow cytometry analysis was used to examine the immunological features of sinus mucosa in both GO and control groups.
Results: Immunohistochemistry showed that the paranasal sinus mucosa of patients with GO grew swelling, with goblet cell and small vessel proliferation, endothelial cell swelling, and inflammatory cell infiltration. The number of T helper (Th)1, Th17, and gamma-delta T cells in nasal sinus mucosa of patients with GO increased significantly compared with those from controls. Further, the proportion of Th1 cells was significantly correlated with clinical activity score. In addition, there was a decreased number of regulatory T cells in patients with GO. The number of Th2 cells showed no significant difference between the two groups. Finally, the proportion of interleukin-22-producing cell subsets in gamma-delta T cells of patients with GO was significantly increased compared with those from controls. Conclusions: Our observations illustrated a potential pathogenic role of mucosal-infiltrating T cells, which may have the possibility to aggravate inflammatory responses in GO.
Copyright © 2021 Lu, Wu, Huang, Fang, Li, Sun and Zhou.

Entities:  

Keywords:  Graves’ orbitopathy; T cells; immune; mucosa; paranasal sinus

Mesh:

Year:  2021        PMID: 33643223      PMCID: PMC7902916          DOI: 10.3389/fendo.2020.621321

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  32 in total

1.  Dominant infiltration of T(H)1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy.

Authors:  D Yang; Y Hiromatsu; T Hoshino; Y Inoue; K Itoh; K Nonaka
Journal:  Thyroid       Date:  1999-03       Impact factor: 6.568

2.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

Authors:  A K Eckstein; B Quadbeck; S Tews; K Mann; C Krüger; C H Mohr; K-P Steuhl; J Esser; R K Gieseler
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

3.  Sinonasal abnormalities in patients with Graves' orbitopathy.

Authors:  Zachary M Soler; Michael P Platt; Man-Kit Leung; Sandy Mong; Ralph Metson
Journal:  Laryngoscope       Date:  2010-11-18       Impact factor: 3.325

4.  Identification of a putative second T-cell receptor.

Authors:  M B Brenner; J McLean; D P Dialynas; J L Strominger; J A Smith; F L Owen; J G Seidman; S Ip; F Rosen; M S Krangel
Journal:  Nature       Date:  1986 Jul 10-16       Impact factor: 49.962

5.  Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin.

Authors:  George J Kahaly; Orly Shimony; Yechiel N Gellman; Simon D Lytton; Lora Eshkar-Sebban; Nir Rosenblum; Efrat Refaeli; Sameer Kassem; Jacob Ilany; David Naor
Journal:  J Clin Endocrinol Metab       Date:  2010-12-08       Impact factor: 5.958

6.  Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy.

Authors:  J P Aniszewski; R W Valyasevi; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

7.  Increased serum interleukin-17 in Graves' ophthalmopathy.

Authors:  Sung Eun Kim; Jin Sook Yoon; Keun Ho Kim; Sang Yeul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-01       Impact factor: 3.117

8.  Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves' ophthalmopathy.

Authors:  Hongfa Wei; Meiping Guan; Yan Qin; Cuihua Xie; Xiajun Fu; Fang Gao; Yaoming Xue
Journal:  Endocr J       Date:  2014-08-07       Impact factor: 2.349

Review 9.  Immune mechanisms in thyroid eye disease.

Authors:  Geniece M Lehmann; Steven E Feldon; Terry J Smith; Richard P Phipps
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

Review 10.  Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications.

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Rosa Bacchetta; Manuela Battaglia
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

View more
  1 in total

1.  Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.

Authors:  Xing Wang; Huijing Ye; Shenglan Yang; Xiaotong Sha; Xiandai Wang; Te Zhang; Rongxin Chen; Wei Xiao; Huasheng Yang
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.